Clinical Trials Directory

Trials / Conditions / Thrombotic Thrombocytopenic Purpura (TTP)

Thrombotic Thrombocytopenic Purpura (TTP)

12 registered clinical trials studyying Thrombotic Thrombocytopenic Purpura (TTP) — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynm
NCT07353099
Takeda—
Not Yet RecruitingA Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
NCT07429942
Takeda—
RecruitingRetrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
NCT07205861
Assistance Publique - Hôpitaux de Paris—
RecruitingA Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
NCT06441578
Takeda—
RecruitingImmunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)
NCT06945861
University Hospital, Rouen—
Active Not RecruitingA Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediate
NCT05714969
TakedaPhase 2
WithdrawnSABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies
NCT05393999
Imperial College Healthcare NHS TrustPhase 2
Active Not RecruitingA Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
NCT04683003
TakedaPhase 3
CompletedA Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)
NCT03393975
Baxalta now part of ShirePhase 3
TerminatedSafety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpur
NCT00411801
OctapharmaPhase 3
CompletedThe Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
NCT00937131
University College, LondonPhase 2
Approved For MarketingExpanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
NCT05770219
Takeda—